The increased risk of breast cancer associated with E+P use was greater among women with at least one rare allele of the CYP1A1 Ile(462)Val , CYP1A1 MspI , CYP1B1 Asn(453)Ser , and PGR Val(660)Leu polymorphisms than among women homozygous for the common allele of these polymorphisms .